Literature DB >> 19191666

Expansion and characterization of human bone marrow-derived mesenchymal stem cells cultured on fragmin/protamine microparticle-coated matrix with fibroblast growth factor-2 in low serum medium.

Satoko Kishimoto1, Hidemi Hattori, Shingo Nakamura, Yoshiko Amano, Yasuhiro Kanatani, Yoshihiro Tanaka, Yasutaka Mori, Yasuji Harada, Masahiro Tagawa, Masayuki Ishihara.   

Abstract

Fragmin/protamine microparticles (F/P MPs) can be stably coated onto plastic surfaces. A capability of F/P MP-coated plates was investigated to immobilize fibroblast growth factor (FGF)-2 as a substratum to expand human bone marrow-derived mesenchymal stem cells (BMMSCs). FGF-2 molecules in low (2%) human serum (HS) medium were immobilized onto F/P MP-coated plates, and the FGF-2 was gradually released into the medium with a half-releasing time of 4-5 days. BMMSCs adhered well to the F/P MP-coated plates, and grew at a doubling time of about 28 h in low (2%) HS medium with FGF-2 (5 ng/mL), while the cells grew at a doubling time of about 30 and 38 h in high (10%) HS medium and in low (2%) HS medium with FGF-2, respectively, without F/P MP coating. The expanded BMMSCs on the F/P MP-coated plates in low (2%) HS medium with FGF-2 maintained their multilineage potential for differentiation into adipocytes and osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19191666     DOI: 10.1089/ten.TEC.2008.0492

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  7 in total

1.  Three-dimensional culture using human plasma-medium gel with fragmin/protamine microparticles for proliferation of various human cells.

Authors:  Satoko Kishimoto; Masayuki Ishihara; Makoto Takikawa; Megumi Takikawa; Yuki Sumi; Shingo Nakamura; Masanori Fujita; Toshinori Sato; Tomoharu Kiyosawa
Journal:  Cytotechnology       Date:  2013-08-17       Impact factor: 2.058

2.  Heterogeneous differentiation of human mesenchymal stem cells in response to extended culture in extracellular matrices.

Authors:  Jose A Santiago; Ryan Pogemiller; Brenda M Ogle
Journal:  Tissue Eng Part A       Date:  2009-12       Impact factor: 3.845

3.  Delivery system for autologous growth factors fabricated with low-molecular-weight heparin and protamine to attenuate ischemic hind-limb loss in a mouse model.

Authors:  Shingo Nakamura; Megumi Takikawa; Masayuki Ishihara; Takefumi Nakayama; Satoko Kishimoto; Susumu Isoda; Yuichi Ozeki; Masahiro Sato; Tadaaki Maehara
Journal:  J Artif Organs       Date:  2012-08-14       Impact factor: 1.731

Review 4.  Biomedical application of low molecular weight heparin/protamine nano/micro particles as cell- and growth factor-carriers and coating matrix.

Authors:  Masayuki Ishihara; Satoko Kishimoto; Makoto Takikawa; Hidemi Hattori; Shingo Nakamura; Masafumi Shimizu
Journal:  Int J Mol Sci       Date:  2015-05-22       Impact factor: 5.923

Review 5.  Recent Progress on Heparin-Protamine Particles for Biomedical Application.

Authors:  Yuuki Hata; Hiromi Miyazaki; Masayuki Ishihara; Shingo Nakamura
Journal:  Polymers (Basel)       Date:  2022-02-25       Impact factor: 4.329

6.  Three-dimensional expansion using plasma-medium gel with fragmin/protamine nanoparticles and fgf-2 to stimulate adipose-derived stromal cells and bone marrow-derived mesenchymal stem cells.

Authors:  Satoko Kishimoto; Masayuki Ishihara; Yasutaka Mori; Megumi Takikawa; Yuki Sumi; Shingo Nakamura; Toshinori Sato; Tomoharu Kiyosawa
Journal:  Biores Open Access       Date:  2012-12

7.  Novel experimental and clinical therapeutic uses of low-molecular-weight heparin/protamine microparticles.

Authors:  Satoko Kishimoto; Masayuki Ishihara; Megumi Takikawa; Yasutaka Mori; Hidemi Hattori; Masanori Fujita; Shingo Nakamura
Journal:  Pharmaceutics       Date:  2012-01-11       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.